Quick Search

  Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home

 
Brands
  Pharmacist Nutriceuticals®
  USA Best®
  USA LABORATORIES®
  USA SPORTS LABS®
Products
  Health Concerns
  Sexual Health
  Specialty Supplements
  Vitamins & Minerals
  --------------------------------------------
  Weight Loss
  --------------------------------------------
  Children's
  --------------------------------------------
  Female
  Male
  --------------------------------------------
  Sports & Athletic Nutrition
  Extreme Hardcore Body Building
  Body Shaping
  Amino Acids
  Proteins
  Carbohydrates
  --------------------------------------------
  Food Bars
  --------------------------------------------
  Branded Ingredients
  --------------------------------------------
  Press Releases
  --------------------------------------------
  Employment
  Company Policy
FAT BURNER™ with Bromelain [click to enlarge]
USASLFB50C - 10.5X8X5 3#

MSRP: $17.99
Internet Direct: $14.99

Bottles:


FAT BURNER™ 50 Capsules
with Bromelain, L-Carnitine, Choline Complex and More!

Pharmacist References:


Choline References:
1. Benjamin J, Levine J. Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995;152:1084-86.

Methionine References:
1. Muller f et al. Elevated plasma concentration of reduced homocysteine in patients with Human Immunodeficiency Virus infection. Am J Clin Nutr 1996;242-46.
2. Revillard JP. Lipid peroxidation in Human immunodefeciency Virus infection. J Acquired Immunode Synd 1992;5:637-38.
3. Singer P et al. Nutritional aspects of the Acquired Immunodefeciency Syndrome. Am J Gastroenter 1992;87:265-73.
4. Tan SV, Guiloff RJ. Hypothesis on the pathongenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J Neurol Neurosurg Psychiat 1998 65:23-25.
5. Keating JN et al. Evidences of brain methyltransferase inhibition and early brain involvement in HIV-positive patients. Lancet 1991;337:935-39.
6. Dorfman D, DiRocco A, Simpson D, et al. Oral methionine may improve neuropsychological function in patients with AIDS myelopathy: results of an open-label trial. AIDS 1997;11:1066-67.
7. Smythies JR, Halsey JH. Treatment of Parkinson's disease with l-methionine. Shouth Med J 1974;77:1577.
8. Uden S, Bilton D, Nathan L, et al. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial. Aliment Pharmacol Ther 1990;4:357-71.
9. Shaw GM, Velle EM, Schaffer DM. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-associated pregnancies? Teratology 1997;56:295-99.
10. Toborek M, Hennig B. Is methionine an atherogenci amino acid? J Optimalt Nutr 1994;3(2):80-8.
11. Leach FN, Braganza JM. Methionine is important in treatment of chronic pancreatitis. Br Med J 1998;316:474 [letter].

Vitamin B6 References:
1. Keniston RC, Nathan PA, Leklem JE, Lockwood Rs. Vitamin B6, vitamin C, and carpal tunnel syndrome. J Occup Environ Med 1997;39:949-59.
2. Franzblau A, Rock CL, Werner RA, et al. The relationship of vitamin B6 status to median nerve function and carpal tunnel syndrome among active industrial workers. J Occup Environ Med 1996;38:485-91.
3. Smith GP, Rudge PJ, Peters TJ. Biochemical studies of pyridoxal and pyridoxal phosphate status and therapeutic trial of pyridoxine in patients with carpal tunnel syndrome. Ann Neurol 1984;15:104-107.
4. Gaby AR. Literature review & commentary. Townsend Letter for Doctors June 1990;338-39.
5. Parry G, Bredesen DE. Sensory neuropath with low-dose pyridoxine. Neurology 1985;35:1466-68.
6. Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse. N England Med 1983;309(8):445-48.

Bromelain References:
1. Izaka K, Yamada M, Kawano T, Suyama. T. Gastrointestinal absorption and anti-infammatory effects of bromelain. Jpn J Pharmacol 1972;22:519-34.
2. Balakrishnan V, Hareendran A, Sukumaran Nair C. Double-blind cross-over trial of an enzyme preparation in pancreatic steatorrhea. J Assoc Phys Ind 1981;29:207-9.
3. Seligman B. Bromelain: An anti-inflammatory agent. Angiology 1962;13:508-10.
4. Cirelli MG. Treatment of inflammation and edema with bromelain. Delaware Med J 1962;34(6):159-67.
5. Masson M. Bromelain in the treatment of blunt injuires to the musculoskeletal system. A case observation study by an orthopedic surgeon in private practive. Fortschr Med 1995;113(19):303-6.
6. Seltzer AP, Minimizing post-operative dedema and ecchymoses by the use of an oral enzyme preparation (bromelain). EENT Monthly 1962;41:813-17.
7. Howat RCL, Lewis GD. The effect of bromelain therapy of episiotomy woulnds-a double blind controlled clinical trial. J Obstet Gynaecol Br Commonwealth 1972;79:951-53.
8. Zatuchni GI, Colombi DJ. Bromelains therapy for the prevention of episiotomy pain. Obstet Gynec 1967;29:275-78.
9. Taub SJ. The use of Ananase in sinusitis. A study of 60 patients. EENT Monthly 1966;45:96-98.
10. Ryan RE. A double-blind clinical evaluation of bromelains in the treatment of acute sinusitis. Headache 1967;7:13-17.

(L-Carnioxtrin-HCL©) L-Carnitine References:
1. Mancini M, Rengo F, Lingetti M, Sorrentino GP, Nolfe G. Controlled study on the therapeutic effica of propionyl-L-carnitine in patients with congestive heart failure. Arzneimittelforschung 1992;42:1101-
2.Giamberardino MA et al. Effects of prolonged L-carnitine adminstration on delayed muscle pain an CK release after eccentric effort. Int J Sports Med 1996;17:320-24.
3. Green RE, Levine AM, Gunning MJ. The effect of L-cartine supplementation on lean body mass male amateur body builders. J AM, Dietet Assoc 1997;(syook):A-72.
4. Murray MT. The many benefits of carnitine. Am J Natural Med 1996;3:6-14 [review].
5. Dal Negro R, Pomari G, et al. L-carnitine and rehabilitative respiratory physiokinesitherapy: metabo and ventilatory response in chronic respiratory insufficiency. Int J Clin Pharmacol Ther Toxicol 1986;24:453-56.
6. Dal Negro R, Turco P, Pomari C, De Conti F. Effects of L-carnitine on physical performance in chronic respiratory insufficiency. Int J Clin Pharmacol Ther Toxicol 1988;26:269-72.
7. Dipalma JR. Carnitine deficiency. Am Family Phys 1988;38:243-51.
8. Kendler BS. Carnitine: an overview of its role in preventive medicine. Prev Med 1986;15:373-90.
9. Del Favero A. Carnitine and gangliosides. Lancet 1988;ii:337 [letter].
10. Kobayashi A, Masumura Y, Yamazaki N. L-carnitine treatment for congestive heart failure-experimental and clinical study. Jpn Circ J 1992;56:86-94.

Lipase References:
1. Hegnhoj J. Hansen CP, Rannem T, et al. Pancreatic function in Crohn's disease. Gut 1990;31:1076-9.

Bioflavonoids References:
1. Peterson J, Dwyer J. Taxonomic classification helps identify flavonoid-containing foods on a semiquantitative food frequency questionnaire. J Am Dietet Assoc 1998;98:682-85.
2. So FV Guthrie N, Chambers AF, et al. Inhibition of human breast cancer cell proliferation and dela of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996;26:167-81.
3. Pamukcu AM, Yalciner S, Hatcher JF, Bryan GT. Quercetin, a rat intestinal and bladder carcinoger present in braken fern (Pteridium aquilinum). Cancer Res 1980;40:3468-72.
4. Hirono I, Ueno I, Hosaka S, Takanashi H, et al. Carcinogenicity examination of quercetin and rutin ACI rats. Cancer Lett 1981;13:15-21.
5. Saito D, Shirai A, Matsushima T, et al. Test of carcinogenticity of quercetin, a widely distributed mutage in food. Teratog Garcinog Mutagen 1980;1:213-21.
6. Aeschbacher H-U, Meier H, Ruch E. Nonmutagenicity in vivo of the food flavonol quercetin. Nutr Cancer 1982;2:90.
7. Nishino H, Nishino A, Iwashima A, et al. Quercetin inhibits the action of 12-O-tetradecanoylphorbol-13acetate, a tumor promoter. Oncology 1984;41:120-23.
8. Kuo SM. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett 1996;110:41-48.
9. Knekt P, Javinen R, Seppanen R, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 1997;146:223-30.
10. Hertog M, Feskens EFM, Hollman PCH, et al. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 1994;22:175-84.
11. Stavric B. Quercetin in our diet: from potent mutagen to probable anticarcinogen. Clin Biochem 1994;27:245-48.
12. Vinson JA, Bose P. Comparative bioavailability to humans of ascorbic acid alone or in a citrus extract. Am J Clin Nutr 1988;48:601-4.
13. Vinson JA, Bose P. Comparative bioavailability of synthetic and natural vitamin C in Guinea pigs. Nutr Rep Intl 1983;27 (4):875.


  • Back To List
  • Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home  l  Return to Top of Page

        Nasvhille Chamber of Commerce Dickson County Chamber of Commerce U.S. Commercial Service

    *These statements have not been evaluated by the F.D.A. *USA Laboratories makes no representation or warranties concerning the use of our products for the diagnosis, cure, mitigation, treatment or prevention of any disease. *Seek advice from a health care provider before using this or any supplement product.

    Powered By LionZone Copyright © USA LABORATORIES, INC. All rights reserved.